Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
100,950,119
-
Total 13F shares
-
67,188,314
-
Share change
-
+2,535,441
-
Total reported value
-
$2,722,920,622
-
Put/Call ratio
-
103%
-
Price per share
-
$40.53
-
Number of holders
-
186
-
Value change
-
+$109,725,641
-
Number of buys
-
102
-
Number of sells
-
68
Institutional Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q2 2020
As of 30 Jun 2020,
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) was held by
186 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,188,314 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, FMR LLC, PRIMECAP MANAGEMENT CO/CA/, PRICE T ROWE ASSOCIATES INC /MD/, HILLHOUSE CAPITAL ADVISORS, LTD., JANUS HENDERSON GROUP PLC, STATE STREET CORP, JPMORGAN CHASE & CO, and FIRST TRUST ADVISORS LP.
This page lists
187
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.